drugset / Trial / NCT06203405

The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial

NCT06203405

Recruiting 214 enrolled Siriraj Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial aims to assess the efficacy of sedation protocol targeting optimal respiratory drive using P0.1 and arousal level compared with conventional sedation strategy (targeting arousal level alone) in patients requiring mechanical ventilation in the medical intensive care unit.

Timeline

Start
2023-12-22
Primary completion
2026-03-31
Completion
2026-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 5 mg Intravenous
Subject Cisatracurium Small molecule 20 mg Intravenous
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg Intravenous
Subject Fentanyl Other / unclassified 25 ug Intravenous
Subject Fentanyl Other / unclassified 75 ug Intravenous
Subject Midazolam Small molecule 0.02 mg/kg Intravenous
Subject Midazolam Small molecule 0.1 mg/kg Intravenous
Subject Propofol Small molecule 5 ug/kg Intravenous
Subject Propofol Small molecule 50 ug/kg Intravenous